Cargando…
Discovery and development of antiviral drugs for biodefense: Experience of a small biotechnology company
The unmet need for effective antivirals against potential agents of bioterrorism and emerging infections is obvious; however, the challenges to develop such drugs are daunting. Even with the passage of Project BioShield and more recently the BARDA legislation, there is still not a clear market for t...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972676/ https://www.ncbi.nlm.nih.gov/pubmed/17765333 http://dx.doi.org/10.1016/j.antiviral.2007.07.003 |